Primary Objective: The primary endpoint of this trial in hospitalized patients is an ordinal outcome based on the patient’s clinical status on Day 7. It includes seven mutually exclusive categories capturing the range of organ dysfunction that may be associated with the progression of COVID-19, such as respiratory dysfunction and coagulation-related complications.
Badan Kebijakan Pembangunan Kesehatan (BKPK)
Building 6, Center 3, 3rd Floor
Jalan Percetakan Negara No. 29
Jakarta, 10560
Indonesia